5002-47-1 Usage
Uses
Used in Pharmaceutical Industry:
Fluphenazine decanoate is used as an antipsychotic agent for the treatment of psychiatric disorders such as schizophrenia. It helps in managing symptoms like hallucinations, delusions, and disorganized thinking associated with these conditions.
Used in Psychotropic Drug Treatments:
Fluphenazine decanoate is used as a long-acting injectable medication for patients who may have difficulty adhering to a daily oral medication regimen. Its long-lasting effects make it a suitable choice for maintaining consistent drug levels in the body and preventing relapses in the treatment of schizophrenia and other related disorders.
Clinical Use
AntipsychoticSchizophrenia and other psychoses
Drug interactions
Potentially hazardous interactions with other drugs Anaesthetics: enhanced hypotensive effect. Analgesics: increased risk of convulsions with
tramadol; enhanced hypotensive and sedative effects
with opioids. Anti-arrhythmics: increased risk of ventricular
arrhythmias with anti-arrhythmics that prolong
the QT interval; increased risk of ventricular
arrhythmias with amiodarone and dronedarone -
avoid; increased risk of ventricular arrhythmias with
disopyramide.Antibacterials: increased risk of ventricular
arrhythmias with delamanid and moxifloxacin -
avoid Antidepressants: increased risk of ventricular
arrhythmias with tricyclics, citalopram, escitalopram;
possible increased risk of convulsions with
vortioxetineAntiepileptics: antagonises anticonvulsant effect.Antimalarials: increased risk of ventricular
arrhythmias with artenimol with piperaquine and
artemether/lumefantrine - avoid.Antipsychotics: increased risk of ventricular
arrhythmias with droperidol, pimozide and
risperidone - avoid; avoid use of depot formulations
with clozapine (cannot be withdrawn quickly if
neutropenia occurs).Antivirals: increased risk of ventricular arrhythmias
with saquinavir - avoid; concentration possibly
increased with ritonavir.Anxiolytics and hypnotics: increased sedative effectsAtomoxetine: increased risk of ventricular
arrhythmias.Beta-blockers: enhanced hypotensive effect;
increased risk of ventricular arrhythmias with sotalolCytotoxics: increased risk of ventricular arrhythmias
with arsenic trioxideDiuretics: enhanced hypotensive effect.Lithium: increased risk of extrapyramidal side effects
and possibly neurotoxicity.Pentamidine: increased risk of ventricular
arrhythmias - avoid.Avoid with drugs that prolong the QT interval.
Metabolism
The cytochrome P450 isoenzyme CYP2D6 is involved in
fluphenazine metabolism.
Check Digit Verification of cas no
The CAS Registry Mumber 5002-47-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,0 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5002-47:
(6*5)+(5*0)+(4*0)+(3*2)+(2*4)+(1*7)=51
51 % 10 = 1
So 5002-47-1 is a valid CAS Registry Number.
InChI:InChI=1/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3
